Ex parte SINGH et al. - Page 23




          Appeal No. 95-0865                                                           
          Application 08/08/007,950                                                    

          2-amino-6-chloropurine, among other compounds, to make the                   
          compound applicants make.                                                    
               Applicants further argue (Appeal Brief, pages 15 and 16)                
          that there would have been no motivation to select the                       
          tetraalkylammonium salt described by Searcey in place of the                 
          known alkali salts.  On this record, we disagree for the reasons             
          given in connection with our explanation of the rejection of                 
          claim 25, infra.                                                             
               Applicants still further argue (Appeal Brief, pages 15 and              
          16-17) that one would not expect an increase in yield (as                    
          described by Searcey) in the process of Bisacchi or Slusarchyk.              
          Again, there are at least two answers to applicants' argument.               
          First, applicants' claims do not require an increased yield.  In             
          fact, applicants' specification does not set out a prior art                 
          problem which is solved by the claimed process.  Second, we                  
          disagree that there is no expectation of success when a purine               
          in its tetraalkylammonium salt form is used.  Example 10 of                  
          Hagberg I demonstrates quite the contrary.  Moreover, given the              
          rather compelling improved yield results described by Searcey, we            
          believe that a person having ordinary skill in the art would have            
          reasonably expected improved yields when a purine in its                     
          tetraalkylammonium form is reacted with a halo-containing                    
          compound to attach the compound to the purine at the 9-position.             
                                        - 23 -                                         





Page:  Previous  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  Next 

Last modified: November 3, 2007